Efficacy of terpenoids in attenuating pulmonary edema in acute lung injury: A meta-analysis of animal studies

Background: The clinical efficiency of terpenoids in treating human acute lung injury (ALI) is yet to be determined. The lipopolysaccharide-induced rat model of ALI is a well-established and widely used experimental model for studying terpenoids’ effects on ALI. Using a systematic review and meta-an...

Full description

Bibliographic Details
Main Authors: Shuai Wang, Sean X. Luo, Jing Jie, Dan Li, Han Liu, Lei Song
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.946554/full
_version_ 1818498779510210560
author Shuai Wang
Sean X. Luo
Jing Jie
Dan Li
Han Liu
Lei Song
author_facet Shuai Wang
Sean X. Luo
Jing Jie
Dan Li
Han Liu
Lei Song
author_sort Shuai Wang
collection DOAJ
description Background: The clinical efficiency of terpenoids in treating human acute lung injury (ALI) is yet to be determined. The lipopolysaccharide-induced rat model of ALI is a well-established and widely used experimental model for studying terpenoids’ effects on ALI. Using a systematic review and meta-analysis, the therapeutic efficiency of terpenoid administration on the lung wet-to-dry weight ratio in rats was investigated.Methods: Using the Cochrane Library, Embase, and PubMed databases, a comprehensive literature search for studies evaluating the therapeutic efficacy of terpenoids on ALI in rats was conducted. The lung wet-to-dry weight ratio was extracted as the main outcome. The quality of the included studies was assessed using the Systematic Review Center for Laboratory Animal Experimentation’s risk of bias tool.Results: In total, 16 studies were included in this meta-analysis. In general, terpenoids significantly lowered the lung wet-to-dry weight ratio when compared with the control vehicle (p = 0.0002; standardized mean difference (SMD): −0.16; 95% confidence interval (CI): −0.24, −0.08). Subgroup analysis revealed that low dose (≤10 μmol/kg) (p < 0.0001; SMD: −0.68; 95% CI: −1.02, −0.34), intraperitoneal injection (p = 0.0002; SMD: −0.43; 95% CI: −0.66, −0.20), diterpenoid (p = 0.004; SMD: −0.13; 95% CI: −0.23, −0.04), and triterpenoid (p = 0.04; SMD: −0.28; 95% CI: −0.54, −0.01) significantly lowered the lung wet-to-dry weight ratio when compared with the control vehicle.Conclusion: A low dose of diterpenoid and triterpenoid administered intraperitoneally is effective in alleviating ALI. This systematic review and meta-analysis provides a valuable mirror for clinical research aiming at the advancement of terpenoids for preventive and therapeutic use.Systematic Review Registration: CRD42022326779
first_indexed 2024-12-10T20:20:15Z
format Article
id doaj.art-4a6c3008d56247f0a7f99798eb9035d0
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-10T20:20:15Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-4a6c3008d56247f0a7f99798eb9035d02022-12-22T01:35:05ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-08-011310.3389/fphar.2022.946554946554Efficacy of terpenoids in attenuating pulmonary edema in acute lung injury: A meta-analysis of animal studiesShuai Wang0Sean X. Luo1Jing Jie2Dan Li3Han Liu4Lei Song5Department of Vascular Surgery, General Surgery Center, The First Hospital of Jilin University, Chasngchun, JL, ChinaDepartment of Vascular Surgery, General Surgery Center, The First Hospital of Jilin University, Chasngchun, JL, ChinaCenter for Pathogen Biology and Infectious Diseases, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, Department of Respiratory Medicine, State Key Laboratory for Zoonotic Diseases, The First Hospital of Jilin University, Changchun, ChinaCenter for Pathogen Biology and Infectious Diseases, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, Department of Respiratory Medicine, State Key Laboratory for Zoonotic Diseases, The First Hospital of Jilin University, Changchun, ChinaCenter for Pathogen Biology and Infectious Diseases, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, Department of Respiratory Medicine, State Key Laboratory for Zoonotic Diseases, The First Hospital of Jilin University, Changchun, ChinaCenter for Pathogen Biology and Infectious Diseases, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, Department of Respiratory Medicine, State Key Laboratory for Zoonotic Diseases, The First Hospital of Jilin University, Changchun, ChinaBackground: The clinical efficiency of terpenoids in treating human acute lung injury (ALI) is yet to be determined. The lipopolysaccharide-induced rat model of ALI is a well-established and widely used experimental model for studying terpenoids’ effects on ALI. Using a systematic review and meta-analysis, the therapeutic efficiency of terpenoid administration on the lung wet-to-dry weight ratio in rats was investigated.Methods: Using the Cochrane Library, Embase, and PubMed databases, a comprehensive literature search for studies evaluating the therapeutic efficacy of terpenoids on ALI in rats was conducted. The lung wet-to-dry weight ratio was extracted as the main outcome. The quality of the included studies was assessed using the Systematic Review Center for Laboratory Animal Experimentation’s risk of bias tool.Results: In total, 16 studies were included in this meta-analysis. In general, terpenoids significantly lowered the lung wet-to-dry weight ratio when compared with the control vehicle (p = 0.0002; standardized mean difference (SMD): −0.16; 95% confidence interval (CI): −0.24, −0.08). Subgroup analysis revealed that low dose (≤10 μmol/kg) (p < 0.0001; SMD: −0.68; 95% CI: −1.02, −0.34), intraperitoneal injection (p = 0.0002; SMD: −0.43; 95% CI: −0.66, −0.20), diterpenoid (p = 0.004; SMD: −0.13; 95% CI: −0.23, −0.04), and triterpenoid (p = 0.04; SMD: −0.28; 95% CI: −0.54, −0.01) significantly lowered the lung wet-to-dry weight ratio when compared with the control vehicle.Conclusion: A low dose of diterpenoid and triterpenoid administered intraperitoneally is effective in alleviating ALI. This systematic review and meta-analysis provides a valuable mirror for clinical research aiming at the advancement of terpenoids for preventive and therapeutic use.Systematic Review Registration: CRD42022326779https://www.frontiersin.org/articles/10.3389/fphar.2022.946554/fullacute lung injuryterpenoidslipopolysaccharidelung wet-to-dry weight ratioanimal model
spellingShingle Shuai Wang
Sean X. Luo
Jing Jie
Dan Li
Han Liu
Lei Song
Efficacy of terpenoids in attenuating pulmonary edema in acute lung injury: A meta-analysis of animal studies
Frontiers in Pharmacology
acute lung injury
terpenoids
lipopolysaccharide
lung wet-to-dry weight ratio
animal model
title Efficacy of terpenoids in attenuating pulmonary edema in acute lung injury: A meta-analysis of animal studies
title_full Efficacy of terpenoids in attenuating pulmonary edema in acute lung injury: A meta-analysis of animal studies
title_fullStr Efficacy of terpenoids in attenuating pulmonary edema in acute lung injury: A meta-analysis of animal studies
title_full_unstemmed Efficacy of terpenoids in attenuating pulmonary edema in acute lung injury: A meta-analysis of animal studies
title_short Efficacy of terpenoids in attenuating pulmonary edema in acute lung injury: A meta-analysis of animal studies
title_sort efficacy of terpenoids in attenuating pulmonary edema in acute lung injury a meta analysis of animal studies
topic acute lung injury
terpenoids
lipopolysaccharide
lung wet-to-dry weight ratio
animal model
url https://www.frontiersin.org/articles/10.3389/fphar.2022.946554/full
work_keys_str_mv AT shuaiwang efficacyofterpenoidsinattenuatingpulmonaryedemainacutelunginjuryametaanalysisofanimalstudies
AT seanxluo efficacyofterpenoidsinattenuatingpulmonaryedemainacutelunginjuryametaanalysisofanimalstudies
AT jingjie efficacyofterpenoidsinattenuatingpulmonaryedemainacutelunginjuryametaanalysisofanimalstudies
AT danli efficacyofterpenoidsinattenuatingpulmonaryedemainacutelunginjuryametaanalysisofanimalstudies
AT hanliu efficacyofterpenoidsinattenuatingpulmonaryedemainacutelunginjuryametaanalysisofanimalstudies
AT leisong efficacyofterpenoidsinattenuatingpulmonaryedemainacutelunginjuryametaanalysisofanimalstudies